Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.

MLA

Gerhardt, Felix, et al. “Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.” Circulation, vol. 149, no. 20, May 2024, pp. 1549–64. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.122.063821.

APA

Gerhardt, F., Fiessler, E., Olsson, K. M., Kayser, M. Z., Kovacs, G., Gall, H., Ghofrani, H. A., Eslam, R. B., Lang, I. M., Benjamin, N., Grünig, E., Halank, M., Lange, T. J., Ulrich, S., Leuchte, H., Held, M., Klose, H., Ewert, R., Wilkens, H., & Pizarro, C. (2024). Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era. Circulation, 149(20), 1549–1564. https://doi.org/10.1161/CIRCULATIONAHA.122.063821

Chicago

Gerhardt, Felix, Eva Fiessler, Karen M. Olsson, Moritz Z. Kayser, Gabor Kovacs, Henning Gall, H. Ardeschir Ghofrani, et al. 2024. “Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.” Circulation 149 (20): 1549–64. doi:10.1161/CIRCULATIONAHA.122.063821.